These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 2986929)

  • 1. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nalbuphine hydrochloride.
    Miller RR
    Am J Hosp Pharm; 1980 Jul; 37(7):942-9. PubMed ID: 6994499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.
    Errick JK; Heel RC
    Drugs; 1983 Sep; 26(3):191-211. PubMed ID: 6137354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceiling effect for respiratory depression by nalbuphine.
    Romagnoli A; Keats AS
    Clin Pharmacol Ther; 1980 Apr; 27(4):478-85. PubMed ID: 7357806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine.
    Lewis JW
    Drug Alcohol Depend; 1985 Feb; 14(3-4):363-72. PubMed ID: 2986930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects and analgesic efficacy of the agonist-antagonist opioids.
    Zola EM; McLeod DC
    Drug Intell Clin Pharm; 1983 Jun; 17(6):411-7. PubMed ID: 6861632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations of agonist-antagonist analgesic dependence.
    Peachey JE
    Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.
    Gear RW; Gordon NC; Hossaini-Zadeh M; Lee JS; Miaskowski C; Paul SM; Levine JD
    J Pain; 2008 Apr; 9(4):337-41. PubMed ID: 18201935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure.
    Picker MJ; Negus SS; Craft RM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):563-8. PubMed ID: 2165617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.